Abivax S.A.
ABVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001956827
No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.
Other share classesAAVXF
Q3 2025 vs. Q2 2025
How the institutions holding Abivax S.A. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 43 | 165 | +122 |
| Shares | 30.7M | 52.0M | +21.3M (+69.5%) |
| Value | $234.6M | $4.41B | +$4.17B (+1,779.2%) |
New holders (130)
Institutions that held Abivax S.A. at the end of Q3 2025 but not at the end of Q2 2025.
Showing the largest 100 of 130 by value.
Sold out (8)
Institutions that held Abivax S.A. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Deep Track Capital, LP | 3,480,144 | $26.6M |
| Kennedy Capital Management, Inc. | 241,188 | $1.85M |
| Allostery Investments LP | 167,350 | $1.28M |
| Soleus Capital Management, L.P. | 125,000 | $956.3K |
| Paloma Partners Management Co | 95,130 | $727.7K |
| GWM Advisors LLC | 30,000 | $229.5K |
| Quadrature Capital Ltd | 19,367 | $148.2K |
| Hurley Capital, LLC | 3,015 | $23.1K |